Preanalytic specimen triage: Smears, cell blocks, cytospin preparations, transport media, and cytobanking
- 13 June 2017
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 125 (S6) , 455-464
Abstract
With increasing requests for the evaluation of prognostic and predictive molecular biomarkers, great attention must be paid to the preanalytical issues regarding sample quality and DNA/RNA yield from all different types of cytological preparations. The objectives of this review were: 1) to provide an update regarding the importance of specimen triage as well as specimen handling and collection; 2) to discuss the different cell preparations that can be used for molecular testing, their advantages and limitations; and 3) to highlight the strategies for biobanking cytology samples. Good‐quality DNA/RNA can be harvested from fresh cells in cell suspensions, formalin‐fixed paraffin‐embedded cell blocks, archival stained smears, archival unstained cytospin preparations, liquid‐based cytology slides, FTA cards, and cryopreserved cells. In contrast to formalin‐fixed paraffin‐embedded tissue specimens (small biopsies and surgical resections), the multitude of types of sample preparations as well as the diversity in sample collection and processing procedures make cytology an ideal specimen for most genomic platforms, with less DNA and RNA degradation and a purer sample, usually with a higher concentration of tumor cells. The broad incorporation of cytological specimens into clinical practice. A should increase the number of samples potentially available for molecular tests and avoid repeat invasive procedures for tissue procurement, thereby increasing patient safety. In this context, it is of utmost importance that cytopathologists become familiar with the variables that can affect test results and embrace the goal of excellence in sample quality. Cancer Cytopathol 2017;125(6 suppl):455‐64. © 2017 American Cancer Society.Keywords
This publication has 61 references indexed in Scilit:
- Minimizing delays in DNA retrieval: The “freezer method” for glass coverslip removal. Letter to the editor regarding comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomasCancer Cytopathology, 2013
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyArchives of Pathology & Laboratory Medicine, 2013
- EZH2 and CD79B mutational status over time in B‐cell non‐Hodgkin lymphomas detected by high‐throughput sequencing using minimal samplesCancer Cytopathology, 2013
- Simple Protocol for DNA Extraction from Archival Stained FNA Smears, Cytospins, and Thin PreparationsActa Cytologica, 2012
- Suitability of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Specimens for Subtyping and Genotyping of Non–Small Cell Lung Cancer: A Multicenter Study of 774 PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma [ERMETIC] Project—Part 1)Journal of Thoracic Oncology, 2011
- American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor TherapyJournal of Clinical Oncology, 2011
- Archival Fine-Needle Aspiration Cytopathology (FNAC) SamplesThe Journal of Molecular Diagnostics, 2010
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European WorkshopJournal of Thoracic Oncology, 2010
- Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancersBritish Journal of Cancer, 2007